ORIGINAL RESEARCH article
Front. Bioeng. Biotechnol.
Sec. Nanobiotechnology
Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1680057
This article is part of the Research TopicAdvancements in Biogenic Nanoparticles: Sustainable Solutions for BiotechnologyView all articles
Detection of biogenic magnetic nanoparticles in rapidly dividing tumor cells by the nonlinear magnetization method
Provisionally accepted- 1Prokhorov General Physics Institute (RAS), Moscow, Russia
- 2FBUN Central'nyj NII epidemiologii Rospotrebnadzora, Moscow, Russia
- 3Naucno-tehnologiceskij universitet Sirius, Sochi, Russia
- 4Moskovskij gosudarstvennyj universitet imeni M V Lomonosova, Moscow, Russia
- 5FBGUN Institut bioorganiceskoj himii im akademikov M M Semakina i U A Ovcinnikova Rossijskoj akademii nauk, Moscow, Russia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Genetically encoded nanoplatforms – bacterial nanocompartments (encapsulins) have demonstrated a remarkable capacity for innovation in the fields of biomedicine and biotechnology. These platforms have found novel applications in a variety of approaches, including magnetic resonance imaging (MRI), transmission electron microscopy (TEM), and high-resolution microscopy, among others. Particular attention has been given to the encapsulin system of the bacterium Quasibacillus thermotolerans (Qt). Divalent iron has been found to sequester within Qt shells, resulting in the formation of biogenic magnetic ferric oxide nanoparticles (MNPs) with T2 contrast properties. Recent studies have led to the successful obtaining of mammalian cells that stably express Qt genes and are capable of producing MNPs. These cells can be detected in vitro and in vivo using both MRI and the nonlinear magnetization method (magnetic particle quantification (MPQ) method). The objective of this study was to investigate the advantages and limitations of labeling mammalian cells with the Qt encapsulins. A rat C6 glioma cell line was engineered to express a red fluorescent protein (RFP) as an optical tag and a Qt nanocompartment as a magnetic tag by lentiviral transduction. The generated C6-RFP-Qt cells were characterized by inductively coupled plasma mass spectrometry (ICP-MS) and Perls staining as well as using the MPQ technique, fluorescent microscopy, and optical tomography. The in vivo study was conducted using severe combined immunodeficient (SCID) mice. A prominent in vivo model of glioblastoma multiforme has undergone substantial enhancement. The magnetic signal retention time in C6-RFP-Qt cells was first estimated by the MPQ technique. The findings indicated the potential for real-time monitoring of magnetic signal amplitude during cell proliferation process utilizing the MPQ method. The approach employed constitutes a simple yet more sensitive alternative to conventional methods for studying MNPs.
Keywords: Magnetic particle quantification, magnetic nanoparticles, Multimodal detection, protein-based nanomaterials, optical imaging
Received: 05 Aug 2025; Accepted: 13 Oct 2025.
Copyright: © 2025 Milovanova, Gabashvili, Mochalova, Gurtovaya, Egorova, Dresviannikova, Griaznova and Nikitin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Petr I Nikitin, nikitin@kapella.gpi.ru
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.